Yahoo Web Search

Search results

1. • Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024

     WRBL Columbus· 2 hours ago

     Expanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell ...

2. • 

     Earnings call: Fate Therapeutics reports on clinical progress and finances By Investing.com

     Investing.com· 1 day ago

     The company's FT819 CAR T-cell therapy showed promise for B-cell-mediated autoimmune diseases, with...

3. • 

     Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of...

     FOX 59 Indianapolis· 4 days ago

     On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of...

4. • AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell...

     Nature· 6 days ago

     Single-cell RNA-seq of primary AML samples and CD4+ T cells before and after their interaction uncovered transcriptional programs that correlate with AML ...

5. • 

     Study highlights need for cell-type-specific therapies in treatment of HIV

     Medical Xpress· 1 day ago

     Researchers from the University of Illinois have demonstrated the importance of cell-type-specific...

6. • 

     Olivia Munn Calls Her Hysterectomy The 'Best Decision' For Her And Her Family

     HuffPost via Yahoo News· 1 day ago

     “I took out my uterus, fallopian tubes, and ovaries.” Munn’s choice to have life-changing surgery...

7. • 

     'Perfect storm' credited for knocking out telecom infrastructure in the North

     CBC via Yahoo News· 2 days ago

     Tammy April, vice...Northwestel, said Yukon's primary fibre line passes through Fort Nelson, B.C....

8. • Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

     WRBL Columbus· 2 hours ago

     "We continue to build momentum in the clinical development of our lead product candidate, KYV-101, as we seek to bring autoimmune CAR T-cell therapies to ...

9. • ...DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML

     Digital Journal· 1 day ago

     This current study extends the successful results previously published on the virus-free preparation of CD19-specific CAR T-cells against refractory B & ...

10. • Small Business - Cordele Dispatch | Cordele Dispatch

      Cordele Dispatch· 14 hours ago

      Alchemab Therapeutics (Alchemab), an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announces the publication of a peer reviewed ...